Bristol-Myers Squibb Holdings Limited

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 52 3000
Fax: +44 (0)1895 52 3010
Medical Information Direct Line: +1 800 749 749
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Patient Information Leaflet last updated on the eMC: 20/01/2012
PIL Vepesid Soft Capsules 50 mg and 100 mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/01/2012 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 31/08/2010 and displayed until 20/01/2012
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to name of manufacturer
Updated on 27/01/2010 and displayed until 31/08/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 14/05/2008 and displayed until 27/01/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
Updated on 01/12/2006 and displayed until 14/05/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to side-effects
Updated on 15/05/2006 and displayed until 01/12/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   etoposide